Artivion, Inc. (AORT)
NYSE: AORT · Real-Time Price · USD
44.59
-0.82 (-1.81%)
Dec 5, 2025, 4:00 PM EST - Market closed
Artivion Employees
Artivion had 1,600 employees as of December 31, 2024. The number of employees increased by 100 or 6.67% compared to the previous year.
Employees
1,600
Change (1Y)
100
Growth (1Y)
6.67%
Revenue / Employee
$264,154
Profits / Employee
-$5,700
Market Cap
2.11B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
AORT News
- 23 days ago - Alger Weatherbie Specialized Growth Fund Q3 2025 Portfolio Update - Seeking Alpha
- 4 weeks ago - Artivion, Inc. (AORT) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Artivion Reports Third Quarter 2025 Financial Results - PRNewsWire
- 4 weeks ago - Artivion Announces Treatment of First Patient with Arcevo LSA in ARTIZEN Pivotal Trial - PRNewsWire
- 5 weeks ago - Artivion to Participate in the Stifel 2025 Healthcare Conference - PRNewsWire
- 6 weeks ago - Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2025 Financial Results - PRNewsWire
- 7 weeks ago - Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE and AMDS PROTECT Trials at the 39th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting - PRNewsWire
- 3 months ago - Artivion, Inc. (AORT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) - Seeking Alpha